For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

The Japan Research Foundation for Clinical Pharmacology, A Daiichi Sankyo Foundation, has awarded 4th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 20, 2011) – Daiichi Sankyo Company, Limited announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology (headquarters: Tokyo, Director General: Kiyoshi Morita) has awarded its 4th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers this year.

 

Awardees are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.

 

The Foundation hopes that the award will motivate young researchers in clinical pharmacology involved in establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentations of the research themes will be held on November 14, 2011.

 

The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and it has worked on a variety of projects relating to clinical pharmacology, including promotion of research, overseas studies for Japanese researchers and Asian international collaborations.

 

 

4th Japan Research Foundation for Clinical Pharmacology Research Awardees

 

Awardees	Organization	Research theme
HIitoshi Ando	Division of Clinical Pharmacology Department of Pharmacology School of Medicine Jichi Medical University	Chronotherapy with raloxifene in patients with postmenopausal osteoporosis.
Kazuma Kiyotani	Center for Genomic Medicine The Institute of Physical and Chemical Research (Present) Division of Genome Medicine Institute for Genome Research The University of Tokushima	Identification of genetic polymorphisms associated with clinical efficacy of adjuvant tamoxifen therapy in breast cancer patients.
Tsuyoshi Shiga	Department of Cardiology Tokyo Women's Medical University	Clinical pharmacological evaluation of antiarrhythmic drug bepridil in patients with paroxysmal or persistent atrial fibrillation.
Mitsutoshi Nakada	Department of Neurosurgery Graduate School of Medical Science Kanazawa University	Silencing of ferrochelatase enhances 5-aminolevulinic acid-based molecular imaging quality and photodynamic therapeutic efficacy.
Masatomo Miura	Department of Pharmacy Akita University Hospital	Development of individualized therapy of mycophenolic acid based on pharmacokinetics, pharmacodynamics and pharmacogenetics.